title: [Calciphylaxis].
abstract: Calciphylaxis is a serious condition including ischaemic, nodular necrosis of the subcutaneous tissue and occlusion of small and medium-sized arteries. The prevalence of calciphylaxis among patients on chronic haemodialysis constitutes 1-4 percent. The condition is associated with high mortality due to co-morbidity. Calciphylaxis seems to be preventable by optimized control of calcium-phosphorous metabolism in susceptible individuals. New and promising therapies are evolving. It is important to focus on this condition in order to provide the relevant therapy to the affected cases.
authors.affiliation: Odense Universitetshospital, Endokrinologisk Afdeling M, DK - 5000 Odense C. Knud.yderstraede@ouh.regionsyddanmark.dk
authors.forename: Knud Bonnet
authors.initials: KB
authors.lastname: Yderstraede
authors.forename: Ole
authors.initials: O
authors.lastname: Clemmensen
authors.forename: Anna Marie
authors.initials: AM
authors.lastname: Nielsen
authors.forename: Peter
authors.initials: P
authors.lastname: Marckmann
authors.forename: Anette
authors.initials: A
authors.lastname: Bygum
mesh_terms: D001158:Arteries / Q000473:pathology; D002115:Calciphylaxis / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects; D012867:Skin / Q000473:pathology